Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,755 | 1,690 | 3,340 | 1,073 | 1,273 |
| Cost of Goods | 1,458 | 1,432 | 980 | 406 | 262 |
| Gross Profit | 297 | 258 | 2,360 | 667 | 1,011 |
| Operating Expenses | 13,019 | 12,232 | 17,678 | 23,685 | 20,313 |
| Operating Income | -12,264 | -11,542 | -14,338 | -22,612 | -19,040 |
| Interest Expense | 0 | 0 | 650 | 975 | 955 |
| Other Income | 140 | 170 | -1,316 | 666 | 507 |
| Pre-tax Income | -12,124 | -11,372 | -16,304 | -22,921 | -19,488 |
| Net Income Continuous | -12,124 | -11,372 | -16,304 | -22,921 | -19,488 |
| Net Income | $-12,124 | $-11,372 | $-16,304 | $-22,921 | $-19,488 |
| EPS Basic Total Ops | -1.31 | -1.20 | -6.00 | -8.40 | -7.25 |
| EPS Basic Continuous Ops | -1.31 | -1.15 | -6.00 | -8.45 | -7.25 |
| EPS Diluted Total Ops | -1.31 | -1.20 | -6.00 | -8.40 | -7.25 |
| EPS Diluted Continuous Ops | -1.31 | -1.15 | -6.00 | -8.45 | -7.25 |
| EPS Diluted Before Non-Recurring Items | -1.31 | -2.75 | -6.00 | -8.40 | -7.20 |
| EBITDA(a) | $-12,152 | $-11,429 | $-14,223 | $-22,408 | $-18,839 |